The company was established in 1999, focusing on providing supports and technologies developed exclusively by the Australian firm Progen. The company primarily conducts tests on medicines that aim for terminal cancer treatments. It has then developed its own cell biology labs and molecular biology labs, focusing in particular on the oncological and immunological experiments.
Headquarters
14F.,Bldg.F,No.3,Yuancyu St, Nangang District
Taipei City; Taipei City;
Contact Details: Purchase the Medigen Biotechnology Corporation report to view the information.
Website: http://www.medigen.com.tw
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service